FindTrial
Sign In

Long-term Outcome of Hospitalized Patients with Acute Severe Ulcerative Colitis Treated with Infliximab: Multicenter Retrospective Cohort Study in Korea)

Long-term Outcome of Hospitalized Patients with Acute Severe Ulcerative Colitis Treated with Infliximab: Multicenter Retrospective Cohort Study in Korea)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0002799
Enrollment
500
Registered
2018-04-16
Start date
2018-03-05
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Kyung Hee University Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Patients who were hospiatlized for acute severe UC and satisfying Truelove and Witts criteria for severe colitis; = 6 bloody stools per day and one or more of the following: decreased hemoglobin (<10.5 g/dL), elevated ESR (>30 mm/h), fever (>37.8?), or tachycardia (>90 bpm)

Exclusion criteria

Exclusion criteria: ? Patients who were not treated with steroid or anti-TNF agents. ? Patients diagnosed with an unclassified-IBD

Design outcomes

Primary

MeasureTime frame
Colectomy;Rehospitalization due to aggravation or complication of disease;Rate of death—

Secondary

MeasureTime frame
Predictive factors for initial treatment failure, colectomy, rehospitalizaion and death;Investigate the annual trends in prevalence of CMV colitis and the effect of antiviral treatment and characteristics of recurrent CMV colitis in patients with ASUC;Trend analysis of standard hospitalization, rehospitazliation, colectomy, and death due to acute severe ulcerative colitis—

Countries

Korea, Republic of

Contacts

Public ContactShin Ju Oh

Kyung Hee University Hospital

linus204@naver.com+82-2-958-8200

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026